Meyer Pierre-Francois について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Ashton Nicholas J. について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Ashton Nicholas J. について
Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden について
Ashton Nicholas J. について
King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK について
Ashton Nicholas J. について
NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK について
Karikari Thomas K. について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Karikari Thomas K. について
NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK について
Strikwerda-Brown Cherie について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Kobe Theresa について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Gonneaud Julie について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Pichet Binette Alexa について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Pichet Binette Alexa について
Department of Psychiatry, McGill University, Montreal, Quebec, Canada について
Pichet Binette Alexa について
McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada について
Ozlen Hazal について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Yakoub Yara について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Simren Joel について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Simren Joel について
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden について
Pannee Josef について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Pannee Josef について
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden について
Lantero-Rodriguez Juan について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Labonte Anne について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Baker Suzanne L. について
Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA について
Scholl Michael について
Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden について
Vanmechelen Eugeen について
ADx NeuroSciences, Ghent, Belgium について
Breitner John C. S. について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Breitner John C. S. について
Department of Psychiatry, McGill University, Montreal, Quebec, Canada について
Breitner John C. S. について
McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada について
Zetterberg Henrik について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Zetterberg Henrik について
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden について
Zetterberg Henrik について
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK について
Zetterberg Henrik について
UK Dementia Research Institute at UCL, London, UK について
Blennow Kaj について
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden について
Blennow Kaj について
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden について
Poirier Judes について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Poirier Judes について
Department of Psychiatry, McGill University, Montreal, Quebec, Canada について
Villeneuve Sylvia について
Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada について
Villeneuve Sylvia について
Department of Psychiatry, McGill University, Montreal, Quebec, Canada について
Villeneuve Sylvia について
McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada について
Villeneuve Sylvia について
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada について
Annals of Neurology について
質量分析 について
血漿 について
皮質 について
免疫沈降反応 について
母集団 について
ロバスト性 について
Alzheimer病 について
病理 について
PET【トモグラフィー】 について
バイオマーカー について
ボクセル について
認知症 について
認知障害 について
単一分子 について
アミロイドβ42 について
神経系の診断 について
高齢者 について
血漿 について
PET について
バイオマーカー について
認知 について